Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Clinical trial NCT07001748 · RECRUITING

Trial details

NCT number: NCT07001748
Sponsor: ECOG-ACRIN Cancer Research Group
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Peritoneal Carcinomatosis

Start date: 2025-08-19
Primary completion: 2030-05-30
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.